{
    "organizations": [],
    "uuid": "f4f9b7cc2a508a84f9e8e898672189f534f76416",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-abeona-therapeutics-provides-clini/brief-abeona-therapeutics-provides-clinical-update-on-mps-iiia-gene-therapy-trial-idUSASC0A2XQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Abeona Therapeutics Provides Clinical Update On MPS IIIA Gene Therapy Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 18 (Reuters) - Abeona Therapeutics Inc:\n* ABEONA THERAPEUTICS PROVIDES CLINICAL UPDATE ON MPS IIIA GENE THERAPY TRIAL AT THE 21ST ANNUAL ASGCT MEETING\n* ABEONA THERAPEUTICS- ABO-102 18-MONTH EFFICACY & SAFETY DATA CONTINUE TO DEMONSTRATE TIME- & DOSE-DEPENDENT REDUCTIONS IN UNDERLYING DISEASE PATHOLOGY\n* ABEONA THERAPEUTICS- RESULTS FROM PHASE 1/2 CLINICAL TRIAL FOR ABO-102 SHOW DURABLE BIOPHYSICAL REDUCTIONS OF DISEASE BURDEN\n* ABEONA THERAPEUTICS INC - ABO-102 IS WELL-TOLERATED IN ALL SUBJECTS TO DATE, WITH NO DRUG-RELATED SERIOUS ADVERSE EVENTS REPORTED Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-18T21:36:00.000+03:00",
    "crawled": "2018-05-19T15:31:44.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "abeona",
        "therapeutic",
        "inc",
        "abeona",
        "therapeutic",
        "provides",
        "clinical",
        "update",
        "mp",
        "iiia",
        "gene",
        "therapy",
        "trial",
        "21st",
        "annual",
        "asgct",
        "meeting",
        "abeona",
        "efficacy",
        "safety",
        "data",
        "continue",
        "demonstrate",
        "reduction",
        "underlying",
        "disease",
        "pathology",
        "abeona",
        "result",
        "phase",
        "clinical",
        "trial",
        "show",
        "durable",
        "biophysical",
        "reduction",
        "disease",
        "burden",
        "abeona",
        "therapeutic",
        "inc",
        "subject",
        "date",
        "serious",
        "adverse",
        "event",
        "reported",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}